Julian Englert's team has launched a website letting anyone start designing proteins in a few clicks for the Anthropic x Adaptyv competition. This week's challenge is designing an Ozempic-like drug using the newly released RFD4 model to target the GLP-1 receptor. Over 1,000 submitted designs will be synthesized and tested in an automated biology lab, including whether they activate the cell receptor. All results will be made publicly available, according to the announcement.

AI summary of the linked source — not editorial content.

Story signal · how it spread on X · via Elfa

as of

Related on X Anthropic’s Claude designs show early promise for scorpion antivenom research · 18 accounts · first post

ANTHROPIC reaction
i
Price change from this article’s publication to 24 hours later (CoinGecko). BTC over the same window is shown so a market-wide move is not mistaken for a reaction to this story. Not advice.
+0.1% 24h after publication

$989.48 → $990.67
BTC −0.3% same window

TradersTrader calls tracked by Elfa · not advice

Positioning · ANTHROPIC

Open112 open positions · 81 long · 31 short

Tracked accounts lean long about 97% of the time, so a long-heavy book is normal, not a signal. As of 24 Oct 13:24 UTC.

Whole crypto market, not this story

Crowding4th percentile · vs last 28 days, 50 typical
Pulse 24h9/100 · unusualness of new calls, 0–100, 50 typical, higher means more long than usual
Book97.3% long · 10,847 accounts

As of 25 Oct 05:30 UTC.

Social-monitoring data, not investment advice Elfa prices CoinGeckoas of

Explore the topic

Loading related coverage…

Explore the full feed

Comments

Loading comments…